Spink5 Antibody / Serine protease inhibitor Kazal-type 5, 100 ug

The SPINK5 antibody targets Serine protease inhibitor Kazal-type 5, a secreted protein encoded by the SPINK5 gene that functions as a multi-domain protease inhibitor. Serine protease inhibitor Kazal-type 5 plays a vital role in maintaining epithelial barrier integrity by regulating protease activity within the skin and mucosal surfaces. The protein contains multiple Kazal-type domains that inhibit trypsin-like and chymotrypsin-like proteases, preventing excessive proteolysis of structural and immune components. The SPINK5 antibody enables detection of this essential regulatory protein in epithelial tissues and supports research into skin biology and inflammatory diseases.

Serine protease inhibitor Kazal-type 5 is most highly expressed in the epidermis, particularly in the granular and cornified layers, where it contributes to desquamation and barrier formation. It inhibits kallikreins such as KLK5, KLK7, and KLK14, which are involved in corneodesmosome degradation. The SPINK5 antibody allows investigation of this balance between protease activation and inhibition, providing insight into how SPINK5 ensures skin homeostasis and prevents barrier dysfunction. Mutations or loss of expression lead to unrestrained proteolytic activity, resulting in the autosomal recessive disorder Netherton syndrome.

Netherton syndrome is characterized by ichthyosiform dermatitis, hair shaft abnormalities, and elevated IgE levels due to defective SPINK5-mediated protease control. The SPINK5 antibody is an important diagnostic and research tool for studying the molecular mechanisms underlying this condition. It enables detection of reduced or absent protein expression in patient tissues, confirming pathogenic variants. Experimental models show that loss of Serine protease inhibitor Kazal-type 5 results in disrupted epidermal differentiation and increased inflammation, underscoring its protective role in barrier maintenance.

Beyond dermatological function, Serine protease inhibitor Kazal-type 5 participates in immune regulation and mucosal defense. It modulates protease activity in airway and gastrointestinal epithelia, influencing inflammation and microbial interactions. The SPINK5 antibody supports analysis of these functions by allowing quantification of protein levels under inflammatory or allergic conditions. Studies suggest SPINK5 expression may also influence asthma and atopic dermatitis susceptibility, linking epithelial protease control to immune homeostasis.

The SPINK5 antibody performs effectively in western blotting, immunohistochemistry, and immunofluorescence, showing strong expression in the upper epidermis and secretory epithelia. NSJ Bioreagents provides this antibody with validated specificity and reproducibility for skin biology and immunology research. By enabling precise detection of Serine protease inhibitor Kazal-type 5, the SPINK5 antibody advances understanding of epidermal barrier regulation, protease inhibition, and inflammatory skin disorders.